Elite Pharmaceuticals's total assets for Q3 2026 were $126.41M, an increase of 7.82% from the previous quarter. ELTP total liabilities were $46.10M for the fiscal quarter, a -17.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.